ERBB2 and breast carcinoma: Women who died from breast cancer were older at baseline and diagnosis, and more frequently had larger tumors, positive lymph node status, distant metastasis at diagnosis, and luminal B-like, HER2+ and TNBC tumors compared to the women who were alive.